Related references
Note: Only part of the references are listed.Essential role of suppressor of cytokine signaling 1 (SOCS1) in hepatocytes and macrophages in the regulation of liver fibrosis
Euphrasie Kawila Mafanda et al.
CYTOKINE (2019)
The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance
Xing Huang et al.
AUTOPHAGY (2019)
Targeted and immune therapies for hepatocellular carcinoma: Predictions for 2019 and beyond
Masatoshi Kudo
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer
Xinran Li et al.
NATURE COMMUNICATIONS (2019)
Recognition of HER2 expression in hepatocellular carcinoma and its significance in postoperative tumor recurrence
Ji-Hua Shi et al.
CANCER MEDICINE (2019)
Genomic and Transcriptomic Profiling of Combined Hepatocellular and Intrahepatic Cholangiocarcinoma Reveals Distinct Molecular Subtypes
Ruidong Xue et al.
CANCER CELL (2019)
The role of telomeres and telomerase in cirrhosis and liver cancer
Jean-Charles Nault et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Hepatocyte growth control by SOCS1 and SOCS3
Md Gulam Musawwir Khan et al.
CYTOKINE (2019)
The Role of Angiogenesis in Hepatocellular Carcinoma
Michael A. Morse et al.
CLINICAL CANCER RESEARCH (2019)
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update
Solomon Tadesse et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics
Jianfang Liu et al.
CELL (2018)
Oncogenic Signaling Pathways in The Cancer Genome Atlas
Francisco Sanchez-Vega et al.
CELL (2018)
Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
Bin Wang et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2018)
Cyclin E1 and cyclin-dependent kinase 2 are critical for initiation, but not for progression of hepatocellular carcinoma
Roland Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Mutant p53 in Cancer: Accumulation, Gain-of-Function, and Therapy
Xuetian Yue et al.
JOURNAL OF MOLECULAR BIOLOGY (2017)
Colony-Stimulating Factor 1 Receptor Blockade Inhibits Tumor Growth by Altering the Polarization of Tumor-Associated Macrophages in Hepatocellular Carcinoma
Jian-Yang Ao et al.
MOLECULAR CANCER THERAPEUTICS (2017)
Targeting the Ras/Raf/MEK/ERK pathway in hepatocellular carcinoma
Sufang Yang et al.
ONCOLOGY LETTERS (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Diphthamide Biosynthesis 1 is a Novel Oncogene in Colorectal Cancer Cells and is Regulated by MiR-218-5p
Minghui Liu et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma
Adrian Ally et al.
CELL (2017)
A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations
Yiqun Zhang et al.
CANCER CELL (2017)
Negative regulation of the hepatic fibrogenic response by suppressor of cytokine signaling 1
Rajani Kandhi et al.
CYTOKINE (2016)
A MYC-aurora kinase A protein complex represents an actionable drug target in p53-altered liver cancer
Daniel Dauch et al.
NATURE MEDICINE (2016)
Suppressor of cytokine signaling 1-dependent regulation of the expression and oncogenic functions of p21CIP1/WAF1 in the liver
M. Yeganeh et al.
ONCOGENE (2016)
Global Cancer Statistics, 2012
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications
Benedicte Delire et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2015)
Activated hepatic stellate cells promote angiogenesis via interleukin-8 in hepatocellular carcinoma
Bing Zhu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Expression of pERK and VEGFR-2 in advanced hepatocellular carcinoma and resistance to sorafenib treatment
Francesca V. Negri et al.
LIVER INTERNATIONAL (2015)
Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity
Jae-Cheol Jo et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Advances in targeted therapies for hepatocellular carcinoma in the genomic era
Josep M. Llovet et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2015)
Regulation of MET receptor tyrosine kinase signaling by suppressor of cytokine signaling 1 in hepatocellular carcinoma
Y. Gui et al.
ONCOGENE (2015)
The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma
Steven N. Steinway et al.
PLOS ONE (2015)
G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high-dose cisplatin-induced nephrotoxicity
Lingyun Li et al.
ONCOLOGY REPORTS (2015)
Fibroblast Growth Factor Signaling in Liver Carcinogenesis
Dalbir S. Sandhu et al.
HEPATOLOGY (2014)
The EGFR signalling system in the liver: from hepatoprotection to hepatocarcinogenesis
Carmen Berasain et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Met as a therapeutic target in HCC: Facts and hopes
Silvia Giordano et al.
JOURNAL OF HEPATOLOGY (2014)
Targeting the mTOR pathway in hepatocellular carcinoma: Current state and future trends
Matthias S. Matter et al.
JOURNAL OF HEPATOLOGY (2014)
The Complex Relationship between Liver Cancer and the Cell Cycle: A Story of Multiple Regulations
Xavier Bisteau et al.
CANCERS (2014)
Targeting the insulin-like growth factor pathway in hepatocellular carcinoma
Monica Enguita-German et al.
WORLD JOURNAL OF HEPATOLOGY (2014)
Insights into p53 transcriptional function via genome-wide chromatin occupancy and gene expression analysis
F. Nikulenkov et al.
CELL DEATH AND DIFFERENTIATION (2012)
Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice
Xiaoni Kong et al.
HEPATOLOGY (2012)
Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
Marie-Jose Blivet-Van Eggelpoel et al.
JOURNAL OF HEPATOLOGY (2012)
Targeting Receptor Tyrosine Kinase Pathways in Hepatocellular Carcinoma
Hung Huynh et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2011)
Expression and prognostic role of pan-Ras, Raf-1, pMEK1 and pERK1/2 in patients with hepatocellular carcinoma
L. Chen et al.
EJSO (2011)
SOCS1 controls liver regeneration by regulating HGF signaling in hepatocytes
Yirui Gui et al.
JOURNAL OF HEPATOLOGY (2011)
HCC and angiogenesis: possible targets and future directions
Andrew X. Zhu et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Mitogen-activated protein kinases in hepatocellular carcinoma development
Lihua Min et al.
SEMINARS IN CANCER BIOLOGY (2011)
The Phosphoinositide 3-Kinase Regulatory Subunit p85α Can Exert Tumor Suppressor Properties through Negative Regulation of Growth Factor Signaling
Cullen M. Taniguchi et al.
CANCER RESEARCH (2010)
The murine IL-8 homologues KC, MIP-2, and LIX are found in endothelial cytoplasmic granules but not in Weibel-Palade bodies
Johanna Hol et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
S. Whittaker et al.
ONCOGENE (2010)
Mouse Models of Hepatocellular Carcinoma
Nelson Fausto et al.
SEMINARS IN LIVER DISEASE (2010)
Cdk2 plays a critical role in hepatocyte cell cycle progression and survival in the setting of cyclin D1 expression in vivo
Eric A. Hanse et al.
CELL CYCLE (2009)
Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model
Yue-Fang Liu et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
SOCS1 Links Cytokine Signaling to p53 and Senescence
Viviane Calabrese et al.
MOLECULAR CELL (2009)
The Interleukin-8 Pathway in Cancer
David J. J. Waugh et al.
CLINICAL CANCER RESEARCH (2008)
Demonstration of cooperative contribution of MET- and EGFR-mediated STAT3 phosphorylation to liver regeneration by exogenous suppressor of cytokine signalings
Ekihiro Seki et al.
JOURNAL OF HEPATOLOGY (2008)
Regulation of liver regeneration and hepatocarcinogenesis by suppressor of cytokine signaling 3
Kimberly J. Riehle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Mechanistic and prognostic significance of aberrant methylation in the molecular pathogenesis of human hepatocellular carcinoma
Diego F. Calvisi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Phosphoinositide 3-kinase regulatory subunit p85α suppresses insulin action via positive regulation of PTEN
Cullen M. Taniguchi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Deletion of the SOCS3 gene in liver parenchymal cells promotes hepatitis-induced hepatocarcinogenesis
Hisanobu Ogata et al.
GASTROENTEROLOGY (2006)
Hepatocellular carcinoma pathogenesis: from genes to environment
Paraskevi A. Farazi et al.
NATURE REVIEWS CANCER (2006)
Methylation silencing of SOCS-3 promotes cell growth and migration by enhancing JAK/STAT and FAK signalings in human hepatocellular carcinoma
Y Niwa et al.
ONCOGENE (2005)
Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse
K Ueki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Regulation of the immune system by SOCS family adaptor proteins
S Ilangumaran et al.
SEMINARS IN IMMUNOLOGY (2004)
SOCS1 is a suppressor of liver fibrosis and hepatitis-induced carcinogenesis
T Yoshida et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Liver regeneration: From myth to mechanism
R Taub
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2004)
Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma
B Yang et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Mutations of the BRAF gene in cholangiocarcinoma but not in hepatocellular carcinoma
A Tannapfel et al.
GUT (2003)
SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2
LY Rui et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Share Paper
